The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.00
Bid: 27.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 2.00 (7.407%)
Open: 28.00
High: 28.00
Low: 28.00
Prev. Close: 28.00
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing - Replacement

17 May 2013 15:57

RNS Number : 0436F
Ilika plc
17 May 2013
 



 

The following amendment has been made to the 'Placing' announcement released on 17 May 2013 0700am under RNS No: 9503E1147P to highlight that it was the discretionary clients of Charles Stanley that invested in Ilika and not Charles Stanley Group Plc.

 

All other details remain unchanged.

 

The full amended text is shown below.

Ilika plc

("Ilika" or the "Company")

 

Placing

 

Ilika plc (AIM: IKA), the advanced cleantech materials discovery company, announces that descretionary clients of Charles Stanley have subscribed for 2,375,000 new ordinary shares of 1 pence each ("Ordinary Shares") at a price of 30p per share (the "Subscription"). The Subscription will raise net funds of £709,000 for the Company at a 15% premium to the closing mid-market price on 16 May 2013.

 

Application will be made for the new Ordinary Shares to be admitted to trading on AIM; it is expected that such admission will be effective as at 8.00am on 22 May 2013. The Company's total issued share capital after admission of the new Ordinary Shares will be 48,249,033 Ordinary Shares. The Company does not currently hold any shares in treasury.

 

This figure of 48,249,033 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

Graeme Purdy, Chief Executive of Ilika, added: "We are delighted that discretionary clients of Charles Stanley have decided to increase their investment in our Company at such an important time in its corporate development. Following this placing, net cash will be in excess of £2.5 million, which provides sufficient funding for the current financial year ending April 2014 and beyond."

 

For more information contact:

 

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Numis Securities Limited

Tel: 020 7260 1000

Oliver Cardigan, Nominated Adviser

 

James Black, Corporate Broking

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780

Paul McManus

Mob: 07980 541 893 or ilika@walbrookpr.com

Paul Cornelius

Mob: 07827 879 460 or ilika@walbrookpr.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCARMITMBABBJJ
Date   Source Headline
6th Jul 20217:00 amRNSFinal Results
5th Jul 202111:05 amRNSSecond Price Monitoring Extn
5th Jul 202111:00 amRNSPrice Monitoring Extension
23rd Jun 202111:06 amRNSSecond Price Monitoring Extn
23rd Jun 202111:05 amRNSPrice Monitoring Extension
22nd Jun 20219:02 amRNSPrice Monitoring Extension
21st Jun 20217:00 amRNSTrading Update & Notice of Results
8th Apr 20217:00 amRNSAppointment of Berenberg as Joint Corporate Broker
6th Apr 20217:00 amRNSGoliath manufacturing design collaboration
18th Mar 20217:00 amRNSISO Certification
4th Mar 20215:30 pmRNSHolding(s) in Company
25th Feb 20217:00 amRNSStereax Manufacturing Update
11th Feb 20214:30 pmRNSAward of Share Options
19th Jan 20214:42 pmRNSSecond Price Monitoring Extn
19th Jan 20214:36 pmRNSPrice Monitoring Extension
14th Jan 202111:07 amRNSSecond Price Monitoring Extn
14th Jan 202111:01 amRNSPrice Monitoring Extension
14th Jan 20217:00 amRNSHalf-year Report
12th Jan 20214:37 pmRNSPrice Monitoring Extension
11th Jan 20214:41 pmRNSSecond Price Monitoring Extn
11th Jan 20214:37 pmRNSPrice Monitoring Extension
7th Jan 20214:41 pmRNSSecond Price Monitoring Extn
7th Jan 20214:37 pmRNSPrice Monitoring Extension
6th Jan 20214:42 pmRNSSecond Price Monitoring Extn
6th Jan 20214:39 pmRNSPrice Monitoring Extension
6th Jan 20212:06 pmRNSSecond Price Monitoring Extn
6th Jan 20212:01 pmRNSPrice Monitoring Extension
6th Jan 202111:06 amRNSSecond Price Monitoring Extn
6th Jan 202111:01 amRNSPrice Monitoring Extension
6th Jan 20219:06 amRNSSecond Price Monitoring Extn
6th Jan 20219:00 amRNSPrice Monitoring Extension
29th Dec 20204:36 pmRNSPrice Monitoring Extension
29th Dec 202010:04 amRNSStmnt re Share Price Movement
24th Dec 20201:06 pmRNSHolding(s) in Company
23rd Dec 20204:41 pmRNSSecond Price Monitoring Extn
23rd Dec 20204:36 pmRNSPrice Monitoring Extension
23rd Dec 20202:06 pmRNSSecond Price Monitoring Extn
23rd Dec 20202:01 pmRNSPrice Monitoring Extension
23rd Dec 202011:06 amRNSSecond Price Monitoring Extn
23rd Dec 202011:01 amRNSPrice Monitoring Extension
21st Dec 202010:08 amRNSHolding(s) in Company
9th Dec 202012:42 pmRNSHolding(s) in Company
24th Nov 20205:37 pmRNSHolding(s) in Company
24th Nov 20207:00 amRNSUpdate on Stereax Manufacturing Implementation
11th Nov 20207:00 amRNSTrading Update & Notice of Results
4th Nov 20207:00 amRNSInvestor Webinar
13th Oct 20204:15 pmRNSHolding(s) in Company
23rd Sep 20207:00 amRNSFramework Agreement with UKBIC
22nd Sep 20201:50 pmRNSResult of AGM
26th Aug 20207:00 amRNSStereax® manufacturing plans update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.